More people in Australia die from accidental drug overdoses than in road accidents. More alarmingis that prescription painkillers cause two and a half times more deaths than illicit drugs. This is amajor concern considering one in five Australians live with chronic pain. Prescription Opioid Crisis

Zelda Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF, Zelda): has expanded its human clinical trial program in a clinical trial partnership with the prestigious St Vincent’s Hospital in Melbourne to examine the potential to use certain cannabinoid medications in patients on chronic, high dose opioid pain management therapy. ASX Announcement: Zelda Partners St Vincent’s Hospital on Opioid Reduction Study

Zelda Therapeutics is developing and hopes to soon license medicinal cannabis formulations that treat common medical disorders. The Company has clinical trials underway in autism and insomnia and pre-clinical research rograms progressing in cancers of the breast, pancreas and brain and in diabetes-related cognitive decline. View full report

Zelda Therapeutics Ltd (ASX: ZLD, US OTC: ZLDAF, Zelda or the Company) is pleased to provide an update on its previously announced paediatric brain cancer research project with the prestigious Telethon Kids Institute (“TKI” or “the Institute) in Perth, Western Australia. PAEDIATRIC BRAIN CANCER RESEARCH UPDATE

From the outside, Australia’s attitude to medicinal cannabis looks quite modern. We were one of the first countries in the world to make it legal at a federal level, and its usage for treating illness has been championed by numerous patient groups and public campaigns. ‘Medicinal cannabis: Australia isn’t as progressive as it may seem” – By Dr. Stewart Washer

Zelda Therapeutics Limited (ASX: ZLD, OTCQB: ZLDAF, “the Company” or “Zelda”) is pleased to announce that the company’s ordinary shares have been approved for trading on the OTCQB Venture Market (OTCQB) in the United States of America under the symbol “ZLDAF.” ASX Announcement: Shares Begin Trading in the USA on the OTCQB Venture Market